Human immunodeficiency virus type 1 (HIV-1) adaptation, under selective pressures, likely involves genetic alterations across the genome preferentially associated with viral phenotypes: CCR5-utilizing (R5), CXCR4-utilizing (X4) and the dual tropic (X4R5) viruses. The Env-V3 sequence is currently a major determinant of co-receptor usage, which can be predicted by in silico methodologies. Previous studies have demonstrated specific single nucleotide polymorphisms (SNPs) within C/EBP site I (3T, C-to-T change at position 3), and Sp site III (5T, C-to-T change at position 5) that correlate with late stage HIV-1 disease, and HIV-1-associated dementia (HAD). A co-selected SNP, 3T5T, was also identified within PBMC-derived LTRs from the D REXELMED HIV/AIDS Genetic Analysis (DM) Cohort that was selectively presented with the R5 Env-V3, with specific Tat genotypes, and observed before the onset of neurological impairment. Utilizing the PSSM algorithm, Env-V3 sequences derived from the Los Alamos National Laboratory (LANL) Database and DREXELMED HIV/AIDS Genetic Analysis Cohort, can be classified into X4 and R5 groups, with specific co-linear LTR, Tat, and Vpr genotypic signatures. The high genetic diversities of the X4 Env-V3 exhibited a direct connection with the high genetic diversities of Tat and LTR while the R5 Env-V3 represented the contrary, except Vpr. Differential amino acid (DAA) and differential nucleotide (DN) changes were identified within the R5 sequences, but not in X4, suggesting the existence of a specific R5 genotype signature within the LTR, Tat, and Vpr. Three methodologies were developed to define X4 and R5 subgroups; based on the PSSM algorithm, genetic diversity, and genetic relatedness. The 18-35 residue fragment differential scanning technology was developed, and shown to successfully define the differential sequence regions between the X4 and R5, as well as between the R5 subgroups comparisons, across the LTR, Tat and Vpr sequences. For the first time, utilizing these identified DAA residues within Vpr, and Tat, in silico prediction technology was established with at least 85% co-receptor usage prediction accuracy. These results leads to further definition of the next generation diagnostic and prognostic tools to examine HIV disease and to develop new therapeutics and vaccines to prevent and treat HIV/AIDS.
Metrics
16 File views/ downloads
16 Record Views
Details
Title
Identification of HIV-1, X4, R5, and R5 subgroup genetic signatures in the viral promoter, Tat, and Vpr
Creators
Benjamas Aiamkitsumrit
Contributors
Brian Wigdahl (Advisor)
Awarding Institution
Drexel University
Degree Awarded
Doctor of Philosophy (Ph.D.)
Publisher
Drexel University; Philadelphia, Pennsylvania
Number of pages
xxvii, 444 pages
Resource Type
Dissertation
Language
English
Academic Unit
Microbiology and Immunology; College of Medicine; Drexel University
Other Identifier
991014970339804721
Research Home Page
Browse by research and academic units
Learn about the ETD submission process at Drexel
Learn about the Libraries’ research data management services